2014-08-19 semperit h1 2014 v15 · 2014. 8. 19. · investor presentation h1 2014 i 19 august 2014...

1

SEMPERIT GROUPINVESTOR PRESENTATIONH1 201419 August 2014

Operational Development (p. 3)

Outlook (p. 13)

Appendix (p. 16)

Agenda

2 Investor Presentation H1 2014 I 19 August 2014 I Investor Relations

Financial Performance (p. 7)

Key Highlights H1 2014: Organic growth and high profitability

3

Medical and Industrial Sectors with satisfying development

Double-digit volume growth and high capacity utilisation compensate declining price levels due to low raw material prices

Organic growth driven by strong sales performance

Further globalisation of business shows positive results

Revenue +2.9% to EUR 464.3m in H1 2014

EBITDA +4.6% to EUR 68.8m, EBIT +5.7% to EUR 46.2m

Strong performance in challenging times

Revenue by segment H1 2014 (vs. H1 2013)

Sempermed48% (48%)

Semperform14% (14%)

Semper-trans15% (18%)

Semperflex23% (20%)

Europe60% (62%)

Asia, Africa, Others18% (16%)

North and South America 22% (22%)

Revenue by region H1 2014 (vs. H1 2013)

Investor Presentation H1 2014 I 19 August 2014 I Investor Relations

Medical Sector:Sempermed on growth track

4

Continuous strong market demand

Examination gloves: Double digit sales growth

Strong demand in Europe, weaker development in the USA

Non-medical area with increased sales

Surgical gloves with stable sales

Ongoing high capacity utilisation

Business Development


Ongoing discussions with Sri Trang about the 50/50 joint venture

Realignment of glove distribution supports growth strategy

Production in Thailand continues close to full capacity

Joint VentureThailand

Industrial Sector: Ongoing strong performance


Excellent sales performance in all business units

Markets calm down

Hydraulic hoses: Rising market shares in Europe and the USA

Industrial hoses: Strong in Europe, ongoing success in Asia

Solid volume growth but negative price effects

Positive development in Europe and South America

Negatively impact for sales in crisis regions (Ukraine, Middle East…), some deliveries have been delayed

Capacities well utilised

Semperflex

Sempertrans

Building profiles with strong sales but increased uncertainty in Russia and the Ukraine

Handrails with sound volume growth worldwide and expansion of production facility in China

Industrial moulded parts with satisfying but volatile development

Semperform


Outlook (p. 13)

Appendix (p. 16)

Agenda



H1 2014: Ongoing growth

7

H1 2014 H1 2013 %

220.6 218.3 +1.1%

29.2 28.2 +3.6%

13.3% 12.9% +0.4 pp

17.4 17.1 +1.6%

7.9% 7.8% +0.1 pp

in EUR m

Revenue

EBITDA

EBITDA margin

EBIT

EBIT margin

Earnings after tax

Earnings per share in EUR2)

CAPEX

Employees (at reporting date)

Medical Sector Industrial Sector

H1 2014 H1 2013 %

243.7 233.1 +4.5%

49.7 45.1 +10.1%

20.4% 19.4% +1.0 pp

39.1 34.3 +13.9%

16.0% 14.7% +1.3 pp

Semperit Group1)


1) Including Corporate Center costs of EUR 10.3m in H1 2014 (EUR 7.8m in H1 2013)2) Attributable to the shareholders of Semperit AG Holding

H1 2014 H1 2013 %

464.3 451.4 +2.9%

68.8 65.8 +4.6%

14.8% 14.6% +0.2 pp

46.2 43.7 +5.7%

10.0% 9.7% +0.3 pp

27.8 28.2 -1.5%

1.35 1.36 -0.7%

21.1 19.9 +6.0%

11,155 10,039 +11.1%

Q2 2014 Q2 2013 %

231.6 236.2 -2.0%

35.4 36.4 -2.9%

15.3% 15.4% -0.1 pp

23.9 24.9 -4.2%

10.3% 10.6% -0.3 pp

14.7 15.8 -6.7%

0.72 0.76 -5.6%

11.2 10.1 +10.8%

11,155 10,039 +11.1%

Q2 2014: Sound development but lower prices

Q2 2014 Q2 2013 %

106.5 111.6 -4.5%

13.5 16.0 -15.7%

12.6% 14.3% -1.7 pp

7.5 10.0 -25.6%

7.0% 9.0% -2.0 pp

in EUR m

Revenue

EBITDA

EBITDA margin

EBIT

EBIT margin

Earnings after tax

Earnings per share in EUR2)

CAPEX

Employees (at reporting date)

Medical Sector Industrial Sector

Q2 2014 Q2 2013 %

125.1 124.7 +0.4%

26.5 24.9 +6.5%

21.2% 19.9% +1.3 pp

21.1 19.4 +8.8%

16.9% 15.6% +1.3 pp

Semperit Group1)

1) Including Corporate Center costs of EUR 4.7m in Q2 2014 (EUR 4.5m in Q2 2013)2) Attributable to the shareholders of Semperit AG Holding

Investor Presentation H1 2014 I 19 August 2014 I Investor Relations8

Medical Sector: Sound revenue and earnings development

in EUR m H1 2014 H1 2013 %

Revenue 220.6 218.3 +1.1%

EBITDA 29.2 28.2 +3.6%

EBITDA margin 13.3% 12.9% +0.4 pp

EBIT 17.4 17.1 +1.6%

EBIT margin 7.9% 7.8% +0.1 pp

H1 2014: Satisfying development

Double digit volume growth compensates negative price effects due to historically low raw material prices

Growth in revenue in H1 2014

Development in Q2 affected by weaker demand in the USA, higher energy costs in Malaysia and infrastructure works by the water utility company in Kamunting/Malaysia

Key Financials Sempermed

Q2 2014 Q2 2013 %

106.5 111.6 -4.5%

13.5 16.0 -15.7%

12.6% 14.3% -1.7 pp

7.5 10.0 -25.6%

7.0% 9.0% -2.0 pp


Industrial Sector:Revenue growth and high profitability

10

Semperflex

Sempertrans

Semperform

Double-digit volume growth and high capacity utilisation

Increase in efficiency and economies of scale realised

Improved profitability with >30% increase in EBITDA and EBIT

Volume growth offset by negative raw material price effects

Good utilisation in Europe and improvements in India and China

Double-digit margins despite lower revenue

Double-digit volume growth in almost all business units offset by negative price effects

Profitability below strong H1 2013 levels due to currency-driven discounts to customers

Double-digit margins in all segments


in EUR m H12014H1

2013 %Q2

2014Q2

2013 %

Revenue 106.7 90.4 +18.0% 53.8 48.0 +12.1%

EBIT 22.0 14.8 +48.5% 11.6 7.9 +47.7%

EBITmargin 20.6% 16.4% +4.2 pp 21.6% 16.4% +5.2 pp

in EUR m H12014H1

2013 %Q2

2014Q2

2013 %

Revenue 71.0 78.4 -9.4% 36.0 41.2 -12.7%

EBIT 8.2 9.8 -16.7% 4.4 5.3 -17.4%

EBITmargin 11.5% 12.5% -1.0 pp 12.1% 12.8% -0.7 pp

in EUR m H12014H1

2013 %Q2

2014Q2

2013 %

Revenue 65.9 64.3 +2.6% 35.3 35.4 -0.4%

EBIT 8.9 9.7 -8.1% 5.1 6.3 -17.9%

EBITmargin 13.6% 15.1% -1.5 pp 14.6% 17.7% -3.1 pp

Strong cash position and very solid balance sheet


1) excl. non-controlling interests2) H1 2013 adjusted, see notes of interim report

in EUR m H1 2014 H1 2013 % Q1 2014

Gross cash flow 57.0 58.5 -2,5% 27.0

Cash flow from operating activities 37.1 52.6 -29.5% 19.3

Cash flow from investment activities2) -19.8 -18.7 -5.9% -8.9

High equity ratio

Positive net liquidity

Positive Cash flow from operating activities

in EUR m 30.6.2014 31.12.2013 % 30.6.2013Cash andcash equivalents 157.3 182.5 -13.8% 111.9

Corporate Schuld-schein loan and bank liabilities

139.8 139.3 +0.3% 107.7

Net liquidity 17.5 43.3 -59.5% 4.2

in EUR m 30.6.2014 31.12.2013 % 30.6.2013

Total assets 856.9 852.1 +0.6% 815.2

Equity1) 418.9 411.5 +1.8% 411.1

Equity ratio 48.9% 48.3% +0.6pp 50.4%


Outlook (p. 13)

Appendix (p. 16)

Agenda



Outlook 2014:Focus on capacity expansion and organic growth

13

Satisfactory development of the Semperit Group expected

Unchanged growth targetsUnchanged growth targets

Continuation of today’s order situation but political risks may impact demand in some local sales markets

Ongoing high capacity utilisation – expansions available step by step in 2015 Satisfactory development of revenue and earnings expected CAPEX of roughly EUR 50-60 million with a focus on capacity expansion in

Poland, Czech Republic and Malaysia

Economic development is negatively impacted by increasing political risks in Russia, Ukraine, Middle East and North Africa

Globally more cautious market and demand developments noted Raw material prices at historic lows – no further decline expected

Double-digit average revenue growth 2010-2015 (CAGR) EBITDA margin of 12 - 15% EBIT margin of 8 - 11%

New market environment – increasing political risks


Contact and Financial Calendar


Investor [email protected]+43 1 79777 - 210www.semperitgroup.com/en/irModecenterstrasse 22 1031 Vienna, Austria

Financial calendar 2014 of Semperit18 November 2014 Report on Q1-3 2014

DisclaimerThe information provided in this presentation does not constitute an offer for the sale of securities nor an invitation to submit an offer to purchase shares of Semperit AG Holding, but exclusively serves information purposes.The forecasts, plans and forward-looking statements contained in this report are based on the knowledge and information available and the assessments made at the time that this report was prepared. As is true of all forward-looking statements, these statements are subject to risk and uncertainties. As a result, the actual events may deviate significantly from these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of planned targets or for any other forward-looking statements.

Financial calendar 2015 of Semperit26 March 2015 Publication of FY 2014 and

press conference28 April 2015 Annual general meeting5 May 2015 Ex-dividend day8 May 2015 Dividend payment day19 May 2015 Report on Q1 201518 August 2015 Report on H1 201517 November 2015 Report on Q1-3 2015


Outlook (p. 13)

Appendix (p. 16)

Agenda



Solid increase in revenue despite negative price effects

Decrease in material costs due lower raw material prices

Rise in personnel expenses due to higher number of employees (esp. Sempermed) and increased wages and salaries

Higher other operating expenses due to higher maintenance costs, outgoing freight charges and strategic projects

Negative financial result due to higher allocations of profit to redeemable non-controlling interests and financial expenses for the corporate Schuldschein loan

Tax rate declines slightly from 19.6% to 19.3% (tax rate is calculated as percentage of earnings before tax and redeemable non-controlling shares)

in EUR m H1 2014H1

2013 %Q2

2014Q2

2013 %

Revenue 464.3 451.4 +2.9% 231.6 236.2 -2.0%

Changes inventories 0.5 9.9 -94.9% 2.6 1.7 +59.6%

Own work capitalised 0.7 0.5 +32.1% 0.2 0.3 -8.3%

Other op. Income 10.3 12.4 -17.6% 4.0 5.9 -33.1%

Material costs -251.3 -264.1 -4.8% -127.1 -133.1 -4.6%

Personnel expenses -83.8 -76.6 +9.4% -42.8 -39.3 +9.0%

Other op. Expenses -72.0 -68.0 +5.9% -33.3 -35.4 -5.8%

EBITDA 68.8 65.8 +4.6% 35.4 36.4 -2.9%

Depreciation -22.6 -22.1 +2.4% -11.5 -11.5 -0.2%

EBIT 46.2 43.7 +5.7% 23.9 24.9 -4.2%

Financial result -9.8 -7.0 +40.1% -4.8 -4.0 +20.2%

EBT 36.4 36.7 -0.8% 19.1 21.0 -8.8%

Income taxes -8.6 -8.5 +1.5% -4.4 -5.2 -15.2%

Earnings after tax 27.8 28.2 -1.5% 14.7 15.8 -6.7%

EPS (EUR) 1.35 1.36 -0.7% 0.72 0.76 -5.6%

Key figures income statement Highlights H1 2014


Significant improvements in revenue and earnings

Solid balance sheet structure

17

in EUR m 30.6.2014 31.12.2013 Change 31.3.2014

Non-current assets 380.5 372.7 +2.1% 370.8

Inventories 147.4 148.4 -0.7% 140.7

Trade receivables 130.7 111.2 +17.5% 127.5

Other current assets incl. deferred taxes 198.3 219.7 -9.8% 227.2

Total assets 856.9 852.1 +0.6% 866.2

in EUR m 30.6.2014 31.12.2013 Change 31.3.2014

Equity 421.4 414.2 +1.8% 426.9

Liabilities from redeemable non-controlling interests 97.0 102.4 -5.3% 106.6

Provisions incl. social capital 72.9 73.7 -1.1% 75.4

Corporate Schuldschein loan 128.5 125.8 +2.2% 125.8

Liabilities incl. deferred taxes 137.1 136.1 +0.7% 131.6

Equity & Liabilities 856.9 852.1 +0.6% 866.2

Highlights H1 2014Key figures balance sheet H1 2014 vs. FY 2013

Balance sheet total almost unchanged

Stable inventories

Cash and cash equivalents down to EUR 157.3m due to payment of dividends

Trade working capital increases to EUR 201.1m (31.12.2013: EUR 186.6m) ► 21.9% of rolling 12-months-revenues (20.6% on 31.12.2013)

Equity excl. non-controlling interests stands at EUR 418.9m (total equity at 421.4m)

Liabilities and provisions almost unchanged to end of 2013 at EUR 435.5m


Key figures 2009 – H1 2014


Key performance figures

in EUR m 20091) 20101) 20111) 20121) 2013 H1 2014Revenue 588.1 689.4 820.0 828.6 906.3 464.3EBITDA 102.8 112.3 110.0 108.7 132.5 68.8EBITDA margin 17.5% 16.3% 13.4% 13.1% 14.6% 14.8%EBIT 69.6 82.3 80.4 72.5 87.8 46.2EBIT margin 11.8% 11.9% 9.8% 8.8% 9.7% 10.0%Earnings after tax 38.8 45.4 51.8 46.2 54.9 27.8Earnings per share (EPS)2), in EUR 1.89 2.21 2.52 2.25 2.65 1.35Gross cash flow 92.6 91.0 89.4 85.6 116.2 57.0Return on equity 12.5% 12.9% 13.6% 11.4% 13.3% 13.3%

Balance sheet key figures

2009¹ 2010¹ 2011¹ 2012 2013 30.06.2014Balance sheet total 531.5 593.5 616.7 824.5 852.1 856.9Equity2) 310.6 351.1 379.4 406.2 411.5 418.9Equity ratio 58.4% 59.2% 61.5% 49.3% 48.3% 48.9%Investments in tangible and intangible assets 22.7 52.5 45.1 41.2 49.7 21.1Employees (at balance sheet date) 6,490 7,019 8,025 9,577 10,276 11,155

1) 2011 values restated (refer to 2012 annual report, notes 2.18), values for 2009 and 2010 not restated.2) Attributable to the shareholders of Semperit AG Holding

2014-08-19 semperit h1 2014 v15 · 2014. 8. 19. · investor presentation h1 2014 i 19 august 2014...

Documents